| Literature DB >> 29940969 |
Alina Świzdor1, Anna Panek2, Paulina Ostrowska1.
Abstract
BACKGROUND: Metabolic activities of microorganisms to modify the chemical structures of organic compounds became an effective tool for the production of high-valued steroidal drugs or their precursors. Currently research efforts in production of steroids of pharmaceutical interest are focused on either optimization of existing processes or identification of novel potentially useful bioconversions. Previous studies demonstrated that P. lanosocoeruleum KCH 3012 metabolizes androstanes to the corresponding lactones with high yield. In order to explore more thoroughly the factors determining steroid metabolism by this organism, the current study was initiated to delineate the specificity of this fungus with respect to the cleavage of steroid side chain of progesterone and pregnenolone The effect of substituents at C-16 in 16-dehydropregnenolone, 16α,17α-epoxy-pregnenolone and 16α-methoxy-pregnenolone on the pattern of metabolic processing of these steroids was also investigated. RESULTS AND DISCUSSION: All of the analogues tested (except the last of the listed) in multi-step transformations underwent the Baeyer-Villiger oxidation to their δ-D-lactones. The activity of 3β-HSD was a factor affecting the composition of the product mixtures. 16α,17α-epoxy-pregnenolone underwent a rare epoxide opening with retention stereochemistry to give four 16α-hydroxy-lactones. Apart from oxidative transformations, a reductive pathway was revealed with the unique hydrogenation of 5-ene double bond leading to the formation of 3β,16α-dihydroxy-17a-oxa-D-homo-5α-androstan-17-one. 16α-Methoxy-pregnenolone was transformed to the 20(R)-alcohol with no further conversion.Entities:
Keywords: 16-dehydropregnenolone; 16α,17α-epoxypregnenolone; Biotransformation; Epoxide opening; Penicillium lanosocoeruleum; Steroid Baeyer–Villiger oxidation; Steroidal lactone
Mesh:
Substances:
Year: 2018 PMID: 29940969 PMCID: PMC6019235 DOI: 10.1186/s12934-018-0948-1
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Fig. 1Metabolic pathway of side-chain cleavage of C21 steroids
Fig. 2X-ray crystal structure of (S)-curvularin (19)
Fig. 3Metabolites isolated following transformation of progesterone (1), pregnenolone (5), 16-dehydro-pregnenolone (8) and 16α,17α-epoxy-pregnenolone (9) by P. lanosocoeruleum
The time course of the transformation of progesterone, pregnenolone and 16-dehydropregnenolone by P. lanosocoeruleum
| Substrate | Rt (min) | Steroidal compounds identified in the mixture (%)a | Time of transformation (h) | ||||
|---|---|---|---|---|---|---|---|
| 9 | 24 | 48 | 72 | 96 | |||
| Progesterone ( | 6.82 | Progesterone ( | 67 | 18 | 6 | 2 | |
| 4.76 | Testosterone ( | 26 | 36 | 3 | – | ||
| 4.54 | Androstenedione ( | 7 | 10 | 5 | 2 | ||
| 8.69 | Testololactone ( | – | 36 | 85 | 88 | ||
| Pregnenolone ( | 5.57 | Pregnenolone ( | 75 | 54 | 34 | 28 | 19 |
| 6.82 | Progesterone ( | 5 | 2 | 3 | 4 | 2 | |
| 4.76 | Testosterone ( | 11 | 13 | 5 | 6 | – | |
| 4.54 | Androstenedione ( | 4 | 3 | 8 | 3 | 3 | |
| 3.51 | DHEA ( | 3 | 4 | 2 | – | – | |
| 6.91 | 3β-Hydroxy-17a-oxa- | – | 2 | 6 | 8 | 5 | |
| 8.69 | Testololactone ( | 2 | 19 | 41 | 44 | 31 | |
| 16-Dehydropregnenolone ( | 5.22 | 16-Dehydropregnenolone ( | 84 | 12 | – | – | |
| 6.91 | 3β-Hydroxy-17a-oxa- | 10 | 75 | 81 | 70 | ||
| 8.69 | Testololactone ( | 5 | 13 | 18 | 30 | ||
aDetermined by GC analysis of the crude chloroform extracts
bIdentified in GC and TLC on the basis of standard
Fig. 4The possible metabolic pathway of 16-dehydro-pregnenolone (8) in P. lanosocoeruleum
Fig. 5The possible metabolic pathway of 16α,17α-epoxy-pregnenolone (9) by P. lanosocoeruleum
The time course of the transformation of 16α,17α-epoxy-pregnenolone and 16α-methoxy-pregnenolone by P. lanosocoeruleum
| Substrate | Rt (min.) | Steroidal compounds identified in the mixture (%)a | Time of transformation (h) | |||
|---|---|---|---|---|---|---|
| 12 | 24 | 48 | 72 | |||
| 16α,17α-Epoxy-pregnenolone ( | 6.38 | 16α,17α-Epoxy-pregnenolone ( | 100 | 93 | 19 | 7 |
| 8.30 | 3β,16α-Dihydroxy-17a-oxa- | – | 2 | 22 | 26 | |
| 8.59 | 16α-Hydroxy-17a-oxa- | – | 1.5 | 31 | 48 | |
| 9.06 | 3β,16α-Dihydroxy-17a-oxa- | – | 1 | 7 | 8 | |
| 9.86 | 16α-Hydroxy-17a-oxa- | – | 0.5 | 5 | 8 | |
| 7.63 | 16α,17α-Epoxy-progesterone ( | – | – | – | – | |
| 6.96 | 16α-Hydroxyandrostenedione ( | – | – | – | – | |
| 16α-Methoxy-pregnenolone ( | 6.23 | 16α-Methoxy-pregnenolone ( | 33 | 8 | 1 | – |
| 7.65 | 16α-Methoxy-progesterone ( | 66 | 86 | 87 | 79 | |
| 8.13 | (20 | 1 | 4 | 12 | 19 | |
aDetermined by GC analysis of the crude chloroform extracts
bIdentified in GC and TLC on the basis of standards
Fig. 6Metabolites isolated following transformation of 16α-methoxy-pregnonolone (16) by P. lanosocoeruleum